Programmed cell death-1 (PD-1) is an inhibitory receptor and plays an important role in the regulation of αβ T cells. Little is known, however, about the role of PD-1 in γδ T cells. In this study, we investigated the expression and function of PD-1 in human γδ T cells. Expression of PD-1 was rapidly induced in primary γδ T cells following antigenic stimulation, and the PD-1+ γδ T cells produced IL-2. When PD-1+ γδ T cells were stimulated with Daudi cells with and without programmed cell death ligand-1 (PD-L1) expression, the levels of IFN-γ production and cytotoxicity in response to PD-L1+ Daudi cells were diminished compared to the levels seen in response to PD-L1− Daudi cells. The attenuated effector functions were reversed by anti-PD-L1 mAb. When PD-1+ γδ T cells were challenged by PD-L1+ tumors pretreated with zoledronate (Zol), which induced γδ TCR-mediated signaling, the resulting reduction in cytokine production was only slight to moderate compared to the reduction seen when PD-1+ γδ T cells were challenged by PD-L1− tumors. In addition, cytotoxic activity of PD-1+ γδ T cells against Zol-treated PD-L1+ tumors was comparable to that against Zol-treated PD-L1− tumors. These results suggest that TCR triggering may partially overcome the inhibitory effect of PD-1 in γδ T cells.